Platelet function testing (PFT) could be a useful clinical tool to guide individualized
antithrombotic treatment in patients with atrial fibrillation (AF) undergoing percutaneous …

OBJECTIVE: Combination and duration of antithrombotic therapy in order to prevent both
stent thrombosis and thromboembolic complications after coronary artery stenting (PCI) in …

Abstract GReek-AntiPlatElet Atrial Fibrillation registry is a multicenter, observational,
noninterventional study of atrial fibrillation patients undergoing percutaneous coronary …

The antithrombotic treatment after percutaneous revascularization in patients with chronic
indication for oral anticoagulation has always been a matter of great interest and complexity …

Observationsstudie; Studieneinschluss Jan-Dez 2013, Beobachtungszeitraum 12 Monate;
real-life Kollektiv; Vergleich DAT (P2Y12–Rezeptor–Antagonisten+ orale Antikoagulation) …

Patients with an indication for oral anticoagulation (OAC) that receive antiplatelet therapy
after percutaneous coronary intervention (PCI) are challenging for the treating physician. It is …

El tratamiento antitrombótico para los pacientes con anticoagulación oral por fibrilación
auricular que se someten a intervención coronaria percutánea es especialmente complejo …

El tratamiento antitrombótico tras una revascularización percutánea en los pacientes con
indicación de anticoagulación oral crónica ha sido siempre un tema de máximo interés y de …

Randomized clinical trials support the use of dual antithrombotic therapy (DAT) in PCI
patients but outcomes in clinical practice are unclear. In this observational study of patients …

The management of antithrombotic treatment in patients who are receiving oral
anticoagulants for atrial fibrillation and who are scheduled for a percutaneous coronary …